Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Buy
55
PHVS Quote, Financials, Valuation and Earnings
Last price:
$27.81
Seasonality move
:
90.96%
Day range:
$27.46 - $29.80
52-week range:
$11.51 - $29.67
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
5.20x
Volume:
3.5M
Avg. volume:
414.1K
1-year change:
38.45%
Market cap:
$1.9B
Revenue:
--
EPS (TTM):
-$3.22
Analysts' Opinion
-
Consensus RatingPharvaris NV has received a consensus rating of Buy. The company's average rating is a Buy based on 8 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $41.87, Pharvaris NV has an estimated upside of 37.14% from its current price of $27.69.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $29.19 representing 0.6% downside risk from its current price of $27.69.
Fair Value
-
According to the consensus of 9 analysts, Pharvaris NV has 37.14% upside to fair value with a price target of $41.87 per share.
PHVS vs. S&P 500
-
Over the past 5 trading days, Pharvaris NV has overperformed the S&P 500 by 15.37% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Pharvaris NV does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Pharvaris NV has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Pharvaris NV reported revenues of --.
Earnings Growth
-
Pharvaris NV has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Pharvaris NV reported earnings per share of -$0.70.
Enterprise value:
1.5B
EV / Invested capital:
4.14x
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
-0.45x
EV / Free cash flow:
-10.43x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$336.8K
Return On Assets:
-57.82%
Net Income Margin (TTM):
--
Return On Equity:
-63%
Return On Invested Capital:
-62.86%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -$254.6K | -$264.8K | -$336.8K | -$47.9K | -$122.9K | |
| Operating Income | -$99.6M | -$138.6M | -$184.6M | -$41.6M | -$46.3M | |
| EBITDA | -$99.3M | -$138.3M | -- | -$41.6M | -$46.2M | |
| Diluted EPS | -$3.22 | -$2.68 | -$3.22 | -$0.85 | -$0.70 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $198.5M | $178.4M | $348.5M | $396.2M | |
| Total Assets | -- | $198.9M | $179.3M | $349.5M | $398.2M | |
| Current Liabilities | -- | $17.4M | $17.1M | $18.3M | $30.8M | |
| Total Liabilities | -- | $17.4M | $17.2M | $18.3M | $31.3M | |
| Total Equity | -- | $181.4M | $162.1M | $331.2M | $366.9M | |
| Total Debt | -- | $194.8K | $308.4K | $130.5K | $679.9K | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$96.8M | -$118.3M | -- | -$37.7M | -$38.2M | |
| Cash From Investing | -$92.5K | -$444.1K | -- | -$338.1K | -$26.8K | |
| Cash From Financing | $69.2M | $283M | -- | $1.1M | $187.5M | |
| Free Cash Flow | -$96.9M | -$118.8M | -- | -$38M | -$38.2M | |
PHVS
Sector
Market Cap
$1.9B
$28.4M
Price % of 52-Week High
98.99%
50.35%
Dividend Yield
0%
0%
Shareholder Yield
-11.61%
-1.32%
1-Year Price Total Return
48.46%
-22.19%
Beta (5-Year)
--
0.521
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$26.76
200-day SMA
Buy
Level
$19.73
Bollinger Bands (100)
Buy
Level
21.26 - 24.88
Chaikin Money Flow
Buy
Level
59.4M
20-day SMA
Buy
Level
$25.02
Relative Strength Index (RSI14)
Buy
Level
58.13
ADX Line
Buy
Level
21.72
Williams %R
Sell
Level
-4.3541
50-day SMA
Buy
Level
$23.70
MACD (12, 26)
Buy
Level
1.16
25-day Aroon Oscillator
Buy
Level
68
On Balance Volume
Neutral
Level
84.8M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (23.0203)
Sell
CA Score
(Annual)
Level (-0.3362)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (4)
Sell
Ohlson Score
Level (8.8161)
--
Piotroski F Score
(Annual)
Level (--)
Sell
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Pharvaris NV is a clinical-stage company, which engages in bringing oral bradykinin B2-receptor antagonists to patients. It focuses on the development and commercialization of innovative therapies for rare diseases focused on angioedema and other bradykinin-mediated diseases. The company was founded by Luc Dochez, Jens Schneider-Mergener, Berndt A. E. Modig, Jochen Knolle, Johannes Gerardus Christiaan Petrus Schikan, and Anne Lesage on September 30, 2015 and is headquartered in Leiden, the Netherlands.
Stock Forecast FAQ
In the current month, PHVS has received 8 Buy ratings 1 Hold ratings, and 0 Sell ratings. The PHVS average analyst price target in the past 3 months is $41.87.
-
Where Will Pharvaris NV Stock Be In 1 Year?
According to analysts, the consensus estimate is that Pharvaris NV share price will rise to $41.87 per share over the next 12 months.
-
What Do Analysts Say About Pharvaris NV?
Analysts are divided on their view about Pharvaris NV share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Pharvaris NV is a Sell and believe this share price will drop from its current level to $29.19.
-
What Is Pharvaris NV's Price Target?
The price target for Pharvaris NV over the next 1-year time period is forecast to be $41.87 according to 9 Wall Street analysts, 8 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is PHVS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Pharvaris NV is a Buy. 8 of 9 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of PHVS?
You can purchase shares of Pharvaris NV via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Pharvaris NV shares.
-
What Is The Pharvaris NV Share Price Today?
Pharvaris NV was last trading at $27.81 per share. This represents the most recent stock quote for Pharvaris NV. Yesterday, Pharvaris NV closed at $27.69 per share.
-
How To Buy Pharvaris NV Stock Online?
In order to purchase Pharvaris NV stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get PHVS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
PHVS
Sector
P/E ratio
--
23.66x
PEG ratio
-0.45x
-0.01x
P/B ratio
5.20x
1.84x
Price / LTM sales
--
1.60x
Growth Metrics
PHVS
Sector
Revenue growth
--
4.85%
Earnings growth
17.74%
11.15%
Revenue (5-year growth)
--
6.45%
Earnings forecast
-$0.78
-$0.20
Profitability
PHVS
Sector
Profitability FY 2024
-$291.6K
$3.6M
Return on invested capital
-62.86%
-30.98%
Return on assets
-57.82%
-27.62%
Return on equity
-63%
-36.69%
Earnings Date
Last Earnings Date
Nov
12
Next Earnings Date
Apr
6
Estimated Next Earnings Date
Feb
11
Balance Sheet
PHVS
Sector
Total cash
$386.9M
$27.2M
Short term investments
--
$25.7M
Total assets
$301.7M
$79.9M
Long term debt
$679.9K
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Sell
50
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 61x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
67
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 40x
Alerts
Sell
47
PSTG alert for Dec 5
Pure Storage, Inc. [PSTG] is up 5.05% over the past day.
Sell
38
HOV alert for Dec 5
Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.
Buy
69
ASTS alert for Dec 5
AST Spacemobile, Inc. [ASTS] is up 18.25% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
